...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: MD&A... Phase 3 European Regulatory Approval

Koo,

The two "treatment" groups are (RVX+atorvastatin) and (RVX + rosuvastatin). The two "control" groups are (placebo+ atorvastatin) and (Placebo+ rosuvastatin).

Bear

Share
New Message
Please login to post a reply